Notably, among all PBC patients, sp100 was detected by ELISA in 17.1% of cases and by immunodot in 17.7%; regarding gp210, ELISA returned positive results in 18.9% and immunodot in 16.5% of cases, respectively (Table 1). This evidence concerns the gene NUP210 and primary biliary cholangitis.